PGR and breast carcinoma: Interestingly, P-cadherin is a marker of triple-negative (which means negative for ER, PgR, and HER2) basal-like breast carcinomas, which comprise a heterogeneous group of tumors that accounts for up to 15% of all breast cancer cases (31).